The Research Of The New Drug Compound Yemazhui Capsule Which Anti-infectious Diseases Of Respiratory System

Respiratory system infectious disease is very common in clinic. With the aggravation of environmental pollution and infection of badness life style, the attack rate such as chronic bronchitis increase year after year. There are about 3.1% patients in total population according to related data. The age of sufferers is younger and younger. On the other hand, the modern medical theories pay more attention to antibiotic drug and glucocorticosteroid, which is expensive and have more adverse reactions. So it is the direction of research that Chinese medicines treat infectious disease of respiratory system in the future. Thus, we choose Eupatorium, Bupleurum root and Scutellaria root as group, carry out preliminary discussion on pharmacology, find it has very effective therapeutic action to model animals. So we have carried the research of pharmacy on the group of Yemazhui.The preparation of medicine is made up of three ingredients of Eupatorium, Scutellaria root, Bupleurum root. The capsule has the efficacy of relieve cough and reduce sputum, relieve asthma, heat-clearing and detoxicating, bacteriostasis. It can be used to cure respiratory system infectious disease. We adopt different extraction, purification methods to each drug separately according to its different effective composition and study systematicly the preparation technology of the three kinds of crude drugs separately. We fill the capsule with pillets. We also study the dessolve in vitro, and find it is a kind of quikly release preparation. The medicine smells sweetness and should be well accepted by patients.In this paper, complied with the standard of new medicine researching of number 6, firstly the author collects literature, then studies on preparation technics, standard of quality, stabilization, pharmacology and the dissolve in vitro of capsule of keping, and gives a summary.